» Articles » PMID: 6219957

Enhancement of Respiratory Syncytial Virus-induced Cytopathology by Trypsin, Thrombin, and Plasmin

Overview
Journal Infect Immun
Date 1983 Apr 1
PMID 6219957
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A series of proteases of diverse substrate specificity were tested for their effect on respiratory syncytial virus-induced cytopathology. Three of the enzymes, thrombin, plasmin, and trypsin, were able to augment significantly the fusion of virus-infected A549 cells. On a concentration basis, thrombin was the most active promoter, followed by plasmin and then trypsin. Hirudin, a specific thrombin inhibitor, blocked the fusion-enhancing property of thrombin, yet had no influence on the basal rate of fusion in the absence of the enzyme. By contrast, the amidine-type inhibitors of trypsin-like proteases, bis(5-amidino-2-benzimidazolyl)-methane (BABIM), blocked not only the thrombin effect, but also the fusion in the thrombin-free controls. The suppressive activity of BABIM was observed at concentrations so low as to exclude any direct inhibitory effect on thrombin itself. These results make it seem very likely that thrombin advances cell fusion by activating a BABIM-sensitive protease. Plasmin and trypsin can be expected to act in a similar manner.

Citing Articles

Host Cell Proteases Involved in Human Respiratory Viral Infections and Their Inhibitors: A Review.

Lubinski B, Whittaker G Viruses. 2024; 16(6).

PMID: 38932275 PMC: 11209347. DOI: 10.3390/v16060984.


Grass carp SERPINA1 inhibits GCRV infection through degrading CF2.

Li Y, Chen L, Huang R, Li Y, Yang C, Gui B Front Immunol. 2022; 13:969517.

PMID: 36159797 PMC: 9494734. DOI: 10.3389/fimmu.2022.969517.


A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity.

Gomez-Carballa A, Rivero-Calle I, Pardo-Seco J, Gomez-Rial J, Rivero-Velasco C, Rodriguez-Nunez N Environ Res. 2022; 210:112890.

PMID: 35202626 PMC: 8861187. DOI: 10.1016/j.envres.2022.112890.


Does Trypsin Oral Spray (Viruprotect/ColdZyme) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union.

Huijghebaert S, Vanham G, Van Winckel M, Allegaert K Int J Environ Res Public Health. 2021; 18(10).

PMID: 34064793 PMC: 8150360. DOI: 10.3390/ijerph18105066.


Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?.

Elrashdy F, Redwan E, Uversky V Biomolecules. 2020; 10(9).

PMID: 32933047 PMC: 7565143. DOI: 10.3390/biom10091312.


References
1.
Shigeta S, Hinuma Y, Suto T, Ishida N . The cell to cell infection of respiratory syncytial virus in HEp-2 monolayer cultures. J Gen Virol. 1968; 3(1):129-31. DOI: 10.1099/0022-1317-3-1-129. View

2.
Kim H, Canchola J, BRANDT C, Pyles G, Chanock R, Jensen K . Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969; 89(4):422-34. DOI: 10.1093/oxfordjournals.aje.a120955. View

3.
Lazarowitz S, Goldberg A, Choppin P . Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen. Virology. 1973; 56(1):172-80. DOI: 10.1016/0042-6822(73)90296-1. View

4.
Scheid A, Choppin P . Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 1974; 57(2):475-90. DOI: 10.1016/0042-6822(74)90187-1. View

5.
Chen L, Buchanan J . Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci U S A. 1975; 72(1):131-5. PMC: 432255. DOI: 10.1073/pnas.72.1.131. View